Patents Examined by Thomas Wiseman
  • Patent number: 4314026
    Abstract: The present invention relates to a process for determining the complement-dependent cytotoxicity mediated by anti-HLA antibodies wherein the cytotoxicity is determined by measuring the loss of intracellular ATP after addition of complement to anti-HLA coated target cells. the invention also relates to an automatical device for ATP determination.
    Type: Grant
    Filed: March 31, 1980
    Date of Patent: February 2, 1982
    Assignee: Institut National de La Sante et de La Recherche Medicale
    Inventor: Beatrice Descamps-Latscha
  • Patent number: 4312942
    Abstract: There is provided a process for extraction of a microorganism, which comprises treating said microorganism with a 4 to 8 molar aqueous solution of a guanidine salt, subsequently washing it to liberate it from the salt and thus obtaining it and diagnostic agents containing a microorganism so extracted.
    Type: Grant
    Filed: October 6, 1977
    Date of Patent: January 26, 1982
    Assignee: Behringwerke Aktiengesellschaft
    Inventors: Hans-Georg Blobel, Werner Schaeg, Jorg Bruckler
  • Patent number: 4311789
    Abstract: A method is provided for sampling and measuring the content of a low-molecular weight compound, such as glucose, cholesterol, or urea, in a complex fluid medium to be sampled, such as blood. A dialyzer is placed in contact with the complex fluid medium so that it passes through the dialyzer. One or more semipermeable membranes are disposed within the complex fluid medium to form one or more passageways for the passage of dialysis fluid, with the passageways being substantially smaller in volume than the volume of the surrounding complex fluid medium. A fractional portion of the complex fluid medium is acted on by the dialysis fluid and dialyzed so that only a fractional portion of the low-molecular weight compound diffuses into the passageways containing the dialysis fluid to produce a dialysate in the passageways. The dialysate is then measured to determine the content of the low-molecular weight compound in the complex fluid medium.
    Type: Grant
    Filed: August 27, 1979
    Date of Patent: January 19, 1982
    Assignee: Gambro AG
    Inventors: Ulf T. G. Nylen, Lars A. G. Qvarnstrom
  • Patent number: 4311791
    Abstract: A diagnostic method is disclosed, based on the automated kinetic determination of LDH and MDH isoenzymes in serum, which utilizes the comparison of two rates of LDH and MDH activity at different concentrations of substrate. A step is eliminated from the procedure previously proposed, significantly improving the method. The method is based on the principle that the pure and hybrid forms of LDH and MDH isoenzymes differ in their affinities for and are inhibited to different extends by their substrate.
    Type: Grant
    Filed: June 10, 1980
    Date of Patent: January 19, 1982
    Inventor: Larry H. Bernstein
  • Patent number: 4310628
    Abstract: Fructose productivity and isomerase activity in immobilized beds or column operations employing isomerases obtained from Bacillus organisms are significantly improved by isomerizing a high solids feed syrup at pH 7.0-7.5 and 55.degree. C. to 60.degree. C. Without adding cobalt to the feed streams, continuous column operation in excess of 4,000 hours and yielding greater than 3,500 pounds of a 42% fructose syrup for each pound of isomerase can be achieved.
    Type: Grant
    Filed: March 14, 1980
    Date of Patent: January 12, 1982
    Assignee: A. E. Staley Manufacturing Company
    Inventor: Roger S. Leiser
  • Patent number: 4306020
    Abstract: A novel composition is disclosed for determining the activity of the alkaline phosphatase, which comprises a salt of p-nitrophenylphosphoric acid, a magnesium salt, sodium borate and 2-amino-2-hydroxymethyl-1,3-propanediol. The composition affords advantages over the known composition especially as regards sensitivity.
    Type: Grant
    Filed: September 25, 1980
    Date of Patent: December 15, 1981
    Assignee: Istituto Sieroterapico E Vaccinogeno Toscano "SCLAVO" S.p.A.
    Inventor: Franco Meiattini
  • Patent number: 3989597
    Abstract: Microbial cells having active enzymes associated therewith are subjected to flocculation conditions to produce a flocculated whole cell aggregate that is useful in effecting enzyme-catalyzed chemical transformations. Substrates are brought into contact with the flocculated cell aggregates where they undergo chemical transformations in the presence of active enzymes associated with the cells.
    Type: Grant
    Filed: October 14, 1975
    Date of Patent: November 2, 1976
    Assignee: R. J. Reynolds Tobacco Company
    Inventors: Chin K. Lee, Margaret E. Long